Co-CEO + Co-Founder · Seuss+ · Clinical Development Partnerships
Execution can be delegated. Responsibility cannot.
Sabine Hutchison writes and speaks on leadership accountability, vendor governance, and partnership integrity across clinical development. Over two decades in life sciences. Based in Hamburg, Germany.
Four beliefs drive the work
Leadership accountability is non-negotiable. Execution can be delegated, but responsibility cannot be outsourced.
Communication breakdown is not a downstream issue. It is an early leadership failure.
Contracts transfer work. They do not transfer accountability.
When vulnerability is punished, reality goes underground, and partnerships quietly lose integrity.
Leadership accountability in clinical development partnerships is non-negotiable.
The belief that drives this work
The industry has become highly sophisticated in science, technology, and vendor ecosystems, but leadership behaviors and partnership norms have not kept pace. Clarity is assumed rather than tested. Accountability is implied rather than defined. Trust is expected without being actively built. Partnerships look productive on the surface while alignment quietly erodes underneath.
Four patterns keep showing up
The context changes. The patterns do not.
Communication Breakdown Is a Leadership Failure
When communication breaks down between sponsor and vendor, it is rarely a conversational issue. It is a leadership issue that surfaced late. Leaders who mistake intent for clarity, or seniority for alignment, create environments where misalignment hardens before it becomes visible in a milestone.
Accountability Does Not Transfer With a Contract
Contracts, governance structures, and reporting lines create the illusion of ownership transfer when a sponsor delegates work. They do not actually transfer accountability. Activity is frequently mistaken for accountability, and the gap surfaces only when outcomes have already compromised.
Vulnerability Must Be Protected to Build Trust
Partnerships do not fail because of honesty. They fail because vulnerability is punished instead of protected. Sponsors who say they want transparency but react defensively when risk is surfaced teach their vendors to stop being honest with them. Trust strengthens only when honesty is met with accountability, not punishment.
The Patient Is the Leadership Compass
Under financial, board, and timeline pressure, patient impact quietly drops out of daily leadership conversations. Leaders who treat patient-centricity as a value statement instead of a decision filter lose the compass. Patient focus persists only when leadership reintroduces it deliberately into trade-offs, governance, and prioritization.
What the data shows
Research referenced in writing →The overall success rate of clinical programs from Phase 1 to regulatory approval. Leadership accountability decisions made early determine which programs fall inside that margin.
Percentage of clinical trials that fail to meet enrollment timelines. Early governance and sponsor-vendor alignment choices are the largest modifiable factor.
Average cost to bring a new drug to market. Governance failures that surface late in a program compound against this figure in rework, delay, and partnership unwinding.
In the press + on the mic
All media + speaking →
Recent writing
All insights →-
When Does the Patient Leave the Room? A Leadership Question for Biotech Sponsors in Clinical Development
Patient focus in clinical development is the deliberate practice of re-centring patient impact in leadership decisions, governance structures, and operational trade-offs throughout the lifecycle…
-
The Most Expensive Assumption in Clinical Development: That Alignment Is Already There
Alignment in a clinical trial partnership is the shared understanding of priorities, roles, decision rights, and expectations that allows sponsors and their vendor partners…
-
Why Your CRO Is Not Telling You What You Need to Know, And What That Costs Your Trial
CROs often withhold early signals of risk, resource pressure, or operational misalignment from sponsors. This is not because they have decided to be dishonest.…
About Sabine
Co-CEO and Co-Founder of Seuss+, a life sciences consultancy supporting biotech and pharmaceutical sponsors across clinical development. More than two decades in clinical operations, governance design, and sponsor-vendor partnership integrity. Operating Board President, EMEA, at the Healthcare Businesswomen’s Association.
Based in Hamburg, Germany. Writing and speaking to senior sponsor leaders on the leadership choices that determine whether clinical partnerships hold under pressure.
Read the full bio and perspective →
The work behind the writing
What Seuss+ does, briefly
Beyond the writing and the speaking, Sabine co-leads Seuss+: a life sciences consultancy that helps biotech and pharma sponsors structure, govern, and hold accountable their clinical vendor relationships. Seuss+’s proprietary framework is the Vendor Relationship Management Methodology (VRMM).
Strategy + selection
Structured decisions on who to work with, and on what terms, before execution begins.
Governance + oversight
The operating rhythm and accountability structures that keep programs aligned when pressure mounts.
Quality + delivery
The systems, documentation, and inspection-readiness needed for delivery integrity.
Invite Sabine
Podcast, conference stage, or feature interview. Sabine regularly appears as a senior voice on clinical leadership, vendor governance, and partnership integrity.
Book for a podcast
Episodes on leadership accountability, vendor governance, and the quiet erosion of partnership alignment.
Request a podcast booking →Invite to speak
Keynotes, panels, fireside chats at biotech, clinical development, and pharma leadership events.
Request a speaking engagement →Request an interview
Press features, expert commentary, and byline contributions on clinical leadership topics.
Request a press interview →Frequently asked
Common questions from journalists, podcast hosts, conference curators, and sponsors considering working with Seuss+.
What does Sabine Hutchison do?+
Sabine Hutchison is Co-CEO and Co-Founder of Seuss+, a life sciences consultancy specializing in sponsor-vendor relationships across clinical development. She writes and speaks on leadership accountability, vendor governance, and the partnership behaviors that determine whether clinical programs hold under pressure. She works with biotech and pharmaceutical sponsors on vendor strategy, governance design, oversight, and execution alignment.
What is the Vendor Relationship Management Methodology (VRMM)?+
VRMM is Seuss+’s proprietary methodology for structuring, assessing, and governing sponsor-vendor relationships across the full clinical development lifecycle. It organizes the work into three clusters: strategy and selection; governance and oversight; quality and delivery. VRMM is a methodology, not a service or a product. It enables the services Seuss+ delivers and anchors Sabine’s thought leadership.
How is Seuss+ different from a CRO?+
Seuss+ is an independent consultancy, not a Contract Research Organization. Seuss+ does not deliver clinical trial execution. It advises sponsors on vendor strategy, selection, governance, oversight, and execution alignment with CROs and other service providers. This independence is deliberate: it lets Sabine comment on accountability and governance across the sponsor-vendor relationship without delivery conflicts.
What does Sabine mean by “accountability cannot be outsourced”?+
Contracts, governance structures, and reporting lines create the appearance of ownership transfer when a sponsor delegates work to a CRO or other vendor. They do not actually transfer accountability. The sponsor organization retains responsibility for outcomes. Activity is frequently mistaken for accountability, and the gap only surfaces when outcomes are already compromised. Sabine’s work reframes accountability as something retained and actively structured throughout a partnership, not delegated with the work itself.
Where is Sabine Hutchison based?+
Sabine is based in Hamburg, Germany. She is American by origin and works globally with biotech and pharmaceutical sponsors. Seuss+ is headquartered in Amsterdam, the Netherlands.
How can I book Sabine for a podcast or speaking engagement?+
Use the booking paths in the Invite Sabine section above. Podcast bookings, speaking invitations, and press interviews each have a dedicated request path. Sabine regularly takes on podcast appearances, conference keynotes, and byline contributions in biotech, clinical development, and pharma leadership media.